Corporate Banner
Satellite Banner
Technology Networks Header
Monday, November 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Multilayer Flask Enhances Cell Culture Production
Friday, May 23, 2014
New 5-layer cell culture flask from Porvair provides easy pipette access.

Powerful Tool for Genomic Editing
Friday, May 23, 2014
CRISPR/Cas9 - Designed to produce a genetically modified cell.

Reliable, Noise-Free Vacuum for Cell Culture Applications
Friday, May 23, 2014
Safe aspiration of cell cultures with VACUSAFE laboratory aspiration system.

New Webinar on How to Accelerate Early Process Development
Thursday, May 22, 2014
New bioprocess webinar presents validation data on ambr15 microbioreactors from a major CMO.

Hepregen Launches First Rat Hepatopac™ Assay Kit
Thursday, May 22, 2014
Application-directed kit complements its human kit counterpart.

XEI Scientific Awarded Patent for New TEM Stage Loader
Wednesday, May 21, 2014
Company has been granted a new US patent # US8716676B2 on May 6, 2014.

Compact Ozone Sterilizer Eliminates Contaminants and Germs
Saturday, May 17, 2014
Ozilla™ - A new high quality, purpose-built ozone gas generator from AMSBIO.

STEMCELL Technologies Releases New MesenCult™ Proliferation Kit with MesenPure™
Saturday, May 17, 2014
A novel cell culture medium to advance research on mouse mesenchymal stem and progenitor cells (MSCs).

A 30 Year Partnership with Agar Scientific
Friday, May 16, 2014
Long-standing relationship helps Dr Young throughout a research career spanning rheumatoid arthritis, ocular degeneration.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 257
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv